Screening of Brazilian medicinal plants for antiviral activity against rotavirus  by Cecílio, Alzira Batista et al.
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Ethnopharmacological  relevance:  Brazilian  medicinal  plants  traditionally  used  for  the treatment  of  diar-
rhoea  were  investigated  for their  in vitro  antiviral  activity  against  the  simian  rotavirus  SA11.
Materials  and methods:  The  ethanolic  crude  extracts  of plants  collected  in  the  cerrado  of  Minas  Gerais,
Brazil  were  submitted  to  phytochemical  screening.  The  cytotoxicity  of the  extracts  was  inferred  by  cel-
lular morphologic  alterations.  Antiviral  activity  was  assessed  by  the  ability  of the  extracts  to  inhibit  the
cytopathic  effect  (CPE)  of  rotavirus  on  the  treated  cells.  RT-PCR  was  performed  to  conﬁrm  and/or  confront
antiviral  assay  data.
Results:  The  maximum  non-toxic  concentration  ranged  from  50 to  500  g/mL.  All  extracts  were toxic  at  a
concentration  of 5000  g/mL but no extract  showed  cytotoxicity  at 50 g/mL.  The  species  Byrsonima  ver-
bascifolia,  Myracrodruon  urundeuva,  Eugenia  dysenterica  and  Hymenaea  courbaril  exhibited  the  strongest
in vitro  activity  against  rotavirus.  Their  extracts  prevented  the  formation  of CPE, and  RT-PCR  analysis
detected  no  ampliﬁcation  of  genetic  material  from  rotavirus.  Tannins,  ﬂavonoids,  saponins,  coumarins
and  terpenes  were  the  major  classes  of natural  products  found  in  the  leaf  extracts  that  showed  antiviral
activity.
Conclusion:  Among  the  species  studied,  Byrsonima  verbascifolia,  Eugenia  dysenterica,  Hymenaea  courbaril
and  Myracrodruon  urundeuva  showed  potential  activity  against  rotavirus  and  are  worthy  of  further  study.
The present  study  corroborates  ethnopharmacological  data  as  a valuable  source  in the  selection  of  plants
with  antiviral  activity  and  to some  extent  validates  their  traditional  uses.
Published by Elsevier Ireland Ltd. Open access under the Elsevier OA license.. Introduction
Rotavirus is the leading cause of severe diarrhoea in new-
orn and young children with a worldwide distribution and
 signiﬁcant public health impact (Black et al., 2010; Walker
t al., 2011). Overall, two million children are hospitalized, and
ore than 500,000 deaths occur annually due to rotavirus dis-
ase in the poorest countries (Atherly et al., 2009). The virus is
ransmitted by the faecal-oral route and its replication causes
amage to cells in the small intestine resulting in diarrhoea
ith vomiting, and an increased loss of electrolytes in the liquid
tool and dehydration (Tallett et al., 1977; Malek et al., 2006).
he only known treatment for rotavirus gastroenteritis is the
∗ Corresponding author. Tel.: +55 31 33144778; fax: +55 31 33144768.
E-mail address: alzira@funed.mg.gov.br (A.B. Cecílio).
378-8741  Published by Elsevier Ireland Ltd.
oi:10.1016/j.jep.2012.03.031
Open access under the Elsevier OA license.replacement of ﬂuids and electrolytes, since there is no speciﬁc
drug against the virus (Farthing, 2001; D’Agostino, 2006; Walker
et al., 2011). In 1999, a highly efﬁcacious rotavirus vaccine licensed
in the United States, RotaShield, was  withdrawn from the market
after 14 months because of its association with intussusceptions.
Two new live, oral, attenuated rotavirus vaccines were licensed
in 2006: RotaRix (GlaxoSmithKline) and RotaTeq (Merck/CSL)
but vaccine effectiveness in preventing rotavirus infections in
populations at highest risk in developing countries remains to
be assessed (Dennehy, 2008). In this scenario, there is growing
interest in the search for novel compounds for the treatment
of diarrhoeal diseases as well as alternative methods to control
rotavirus infection. Despite the advances made with synthetic
products, natural medicine is a valuable ﬁeld of research, since
the biological diversity of nature is the source of a wide range
of bioactive molecules (De Clercq, 2005). It is known that sec-
ondary metabolites have a wide spectrum of biological activities,
including potential antiviral effect (Vlietinck and Vanden Berghe,
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Table 1
Brazilian medicinal plant species studied for their antiviral activity against rotavirus.
Species Voucher Collection site Family Vernacular name Traditional uses Reference
Anacardium humile
A. St. -Hil.
Duarte 1 Santana do
Pirapama
Anacardiaceae Cajuzinho,
cajueiro-do-campo
Diarrhoea, external
ulcers
Agra et al. (2007)
Annona  crassiﬂora
Mart.
Duarte 3 Santana do
Pirapama
Annonaceae Araticum, marolo Cronic diarrhoea Brandão et al.
(1992) and
Rodrigues and
Carvalho (2001)
Astronium
fraxinifolium
Schott
Sobral  et al. 12207 Lagoa Santa Anacardiaceae Gonc¸ alo-alves,
aroeira-vermelha
Diarrhoea, skin
ulcers, toothaches
Almeida et al.
(1998) and Agra
et al. (2007)
Byrsonima
coccolobifolia
Kunth
Sobral et al. 12206 Lagoa Santa Malpighiaceae Murici de ﬂor
rósea,
murici-do-cerrado
Diarrhoea Lorenzi (2002) and
Brandão et al.
(1992)
Byrsonima
verbascifolia (L.)
DC.
Sobral et al. 12205 Lagoa Santa Malpighiaceae Murici de ﬂor
amarela,
murici-cascudo
Fever, diarrhoea,
astringent, mild
laxative
Brandão et al.
(1992) and
Rodrigues and
Carvalho (2001)
Campomanesia
pubescens (DC.)
O. Berg.
Gontijo 3 Mateus Leme Myrtaceae Gabiroba,
guabiroba
Diarrhoea, urinary
tract infections
Rodrigues and
Carvalho (2001)
Curatella americana
L.
Sobral et al. 12209 Lagoa Santa Dilleniaceae Lixeira,
cajueiro-bravo
To wash wounds Brandão et al.
(1992)
Eugenia dysenterica
DC.
Sobral et al. 12208 Lagoa Santa Myrtaceae Cagaiteira, cagaita Diarrhoea,
purgative
Almeida et al.
(1998)
Eugenia uniﬂora L. Gontijo 1 Juatuba Myrtaceae Pitangueira,
pitanga
Diarrhoea,
bronchitis, fever,
verminosis
Panizza (1997) and
Lorenzi and Matos
(2002)
Hymenaea courbaril
L.
Sobral et al. 12204 Lagoa Santa Fabaceae Jatobá, farinheira Diarrhoea,
dysentery,
intestinal colic,
pulmonary
weakness, chronic
cystitis
Panizza (1997) and
Lorenzi and Matos
(2002)
Luehea paniculata
Mart.
Sobral et al. 12210 Lagoa Santa Tiliaceae Ac¸ oita-cavalo,
ivitinga
Dysentery,
rheumatism
Almeida et al.
(1998)
Myracrodruon
urundeuva
(Allemão) Engl.
Duarte 2 Santana do
Pirapama
Anacardiaceae Aroeira,
aroeira-do-sertão
Female genital
tract
antiinﬂammatory,
urinary and
respiratory
diseases, diarrhoea
Lorenzi and Matos
(2002) and Viana
et al. (2003)
Psidium guajava L. Gontijo 2 Juatuba Myrtaceae Goiabeira,
arac¸ á-das-almas
Acute diarrhoea,
intestinal colic,
gastrointestinal
disorders
Matos (2000),
Lorenzi and Matos
(2002) and Gilbert
et al. (2005)
Stryphnodendron
adstringens
(Mart.) Coville
Duarte 4 Santana do
Pirapama
Leguminosae Barbatimão, casca-
da-virgindade
Gynaecological
problems,
diarrhoea,
decubitus ulcers
healing
Lorenzi and Matos
(2002) and Gilbert
et al. (2005)
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Estimates suggest that 70% of drugs for infectious diseases and
7% of anticancer are either natural products or derived from
hem (Cragg and Newman, 2005). Natural products, either pure
ompounds or as standardized plant extracts, provide unlimited
pportunities for the development of new leads (Cos et al., 2006).
he chemical composition of most Brazilian plants is still unknown,
epresenting a potential to be exploited. Phytochemical studies of
pecies within the Fabaceae, Myrtaceae, and others families have
een carry out in order to obtain compounds with antidiarrhoeal
ctivity (Lima et al., 2011).
Furthermore, the study of medicinal plants based on popular
se, can provide useful information for the discovery of new drugs
ith less ﬁnancial burden. An ethnopharmacological approach was
hosen for screening extracts derived from plants used in tradi-
ional medicine to treat infectious diseases such as gastrointestinal
isorders (Simões et al., 1999; Rajbhandari et al., 2001; Cos et al.,
002; Alanís et al., 2005).The aim of this study is to investigate whether leaf extracts of 14
medicinal plants traditionally used for the treatment of diarrhoea
show in vitro antiviral activity against the simian rotavirus SA-11.
Their aerial parts (leaves, fruits, stem barks and seeds) are used in
Brazilian traditional medicine to treat diarrhoea even though other
uses have also been reported (Table 1).
2. Methodology
2.1. Plant material
The species were selected based on their ethnopharmacological
use for treating diarrhoea. The 14 Brazilian medicinal plants stud-
ied are presented in Table 1. They were identiﬁed by Dr. Marcos
Eduardo Guerra Sobral from the Departamento de Ciências Natu-
rais, Universidade Federal de São João Del-Rei. Voucher specimens
were deposited at the Herbarium BHCB from the Instituto de Ciên-
cias Biológicas, Universidade Federal de Minas Gerais. The leaves
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ere collected from adult plants in the cerrado area of Minas Gerais
tate, Brazil, between September 2006 and February 2007.
.2. Preparation of extracts and stock solution
The leaves were dried at 40 ◦C and subsequently powdered. The
xtracts were prepared by percolation of material with ethanol 95◦
L (Vetec Química Fina), until exhaustion at room temperature.
he ethanolic extracts were evaporated under reduced pressure at
0 ◦C. For in vitro experiments, each 50 mg  of extract was solubi-
ized in 1 mL  dimethylsulfoxide (DMSO), centrifuged at 9000 rpm
o given a concentration of 50 mg/mL.
.3. Cells and viruses
The rhesus monkey kidney cell line MA-104 was grown in Dul-
ecco’s modiﬁed Eagle’s medium (DMEM) supplemented with 10%
etal bovine serum (FBS), 100 g/mL (Gibco) and 100 U/mL peni-
illin G (Invitrogen). The cell cultures were maintained at 37 ◦C in
 humidiﬁed 5% CO2 atmosphere. Simian rotavirus SA11 were acti-
ated with 10 g/mL trypsin for 60 min  at 37 ◦C and propagated in
A-104 cells monolayers in presence of 10 g/mL trypsin. The virus
iters were estimated from cytopathogenicity by the limit-dilution
ethod and expressed as 50% tissue culture infectious dose per mL
TCID50/mL) by Reed and Muench (1938).
.4. Determination of the maximum non-toxic concentration
The cytotoxicity of each extract was determined using the
ethod described by Miranda et al. (1997).  This method is based
n cellular morphologic alterations. Concentrations 5000, 500 and
0 g/mL of each extract were placed in contact with conﬂuent
A-104 cells monolayers prepared in 12-well microplates and
ncubated at 37 ◦C in a humidiﬁed 5% CO2 atmosphere for 48 h.
fter the incubation period, the cells were examined using an
nverted optical microscope (Nikon) and treated and untreated cul-
ures (control) were compared. The higher concentration of each
xtract showing no cellular morphologic changes was  considered
s the maximum non-toxic concentration (MNTC).
.5. Antiviral assay
Antiviral activity was assessed by the ability of the extracts to
nhibit the cytopathic effect (CPE) of rotavirus on the treated MA-
04 cells monolayers cultivated in 96-well microplates. The MNTC
f crude extracts were tested in an antiviral assay. The extracts
on-toxic at 500 g/mL were also tested at 50 g/mL. Afterwards,
0 TCID50 and 20 TCID50 of activated rotaviruses were added to
reated and untreated cells. The plates were incubated for 48 h in a
umidiﬁed 5% CO2 atmosphere at 37 ◦C. Experiments were carried
ut in duplicate. The antiviral assay data were conﬁrmed and/or
onfronted by RT-PCR.
.6. RNA extraction
The material collected from the antiviral assay was used to
xtract RNA. RNAs were extracted by a modiﬁed silica method
Boom et al., 1990). Brieﬂy, 60 L of material was treated with
00 L lysis buffer (60 g guanidine isothiocyanate, Invitrogen,
0 mL  of 0.1 M Tris–HCl pH 6.4, Invitrogen, 11 mL  of 0.2 M EDTA pH
.0, Invitrogen, 1.3 g of Triton X-100, Packard Instrument Co.) and
0 L sterilized silica solution (prepared according to Boom et al.,
990). After centrifugation, the silica was washed with a wash-
ng buffer (60 g guanidine isothiocyanate, 50 mL  of 0.1 M Tris–HCl
H 6.4), followed by two washes with 70% ethanol (Merck) and
cetone (Merck). The material was resuspended in water treatedrmacology 141 (2012) 975– 981 977
with diethyl pyrocarbonate 0.1% and after centrifugation the RNA
was collected in the upper phase and maintained at −80 ◦C until
required.
2.7. RT-PCR assay
(i) cDNA synthesis – the cDNA synthesis was  conducted in a 20 L
reaction using Improm IITM Reverse Transcriptase (Promega).
Firstly, 1 g of viral RNA, 1 M of each primer and 7% dimethyl
sulfoxide, were incubated at 95 ◦C for 5 min  and then chilled
on ice for 5 min. After this incubation, 1× reaction buffer was
added, 3 mM MgCl2, 0.5 mM of each dNTP and 1 L Improm IITM
Reverse Transcriptase. The reaction was incubated for 5 min
at 25 ◦C, 60 min  at 42 ◦C, and the enzyme was inactivated for
15 min  at 70 ◦C. The cDNAs were maintained at −80 ◦C until
required.
ii) PCR control – each reaction set was  checked for contamination
using negative control (all reagents included and water instead
of DNA). In addition to this negative control, cells not infected
were included. Each reaction set included the reference sample
SA11 as a positive control.
iii) Primers – the primers used for rotavirus VP6 region
ampliﬁcation were: Rota A – Fwd  1: 5′-GGATGTCCTGTAC-
TCCTTGTCAAAA-3′ and Rota A – Rev 1: 5′-TCCAGTT-
TGGAACTCATTTCCA-3′, which amplify a 144-bp product
(Logan et al., 2006).
iv) PCR assay – the PCR using 5 L of cDNA was  conducted in reac-
tion of 50 L containing 22 mM Tris–HCl pH 8.4, 55 mM KCl,
1.65 mM MgCl2, 220 M each deoxynucleoside triphosphate
(dNTP), 800 nM each primer and 0.5 U recombinant Taq DNA
Polymerase (Invitrogen). The thermal cycle used for rotavirus
ampliﬁcation was 10 min  at 95 ◦C and 30 cycles of 15 s at 95 ◦C,
1 min  at 60 ◦C and 1 min  at 72 ◦C.
(v) Detection of ampliﬁed DNA – 10 L of the PCR ampliﬁed DNA
underwent electrophoresis on a silver stained 8% poliacry-
lamide gel electrophoresis (PAGE).
2.8. Phytochemical screening
The extracts were tested for the presence of different classes
of natural products by thin-layer chromatography (TLC) using
methods described by Wagner and Bladt (2001).  The analysis was
performed on Merck silica gel 60 F254 aluminum plates, which
were developed according to Table 2. Others tests described by
Matos (1997) were carried out to determine the presence of tannins
and saponins. The tannins were detected by proteins precipitation
test while saponins were determined using the foam test.
3. Results
In this study, ethanolic crude extracts from 14 medicinal species
of 8 different botanical families (Table 1) were studied to detect
antiviral activity against rotavirus and were also submitted to phy-
tochemical screening.
The cytotoxicity of the extracts was  determined by optical
microscopy examination of the morphology integrity of MA-104
cells after an incubation period of 48 h. Fig. 1 shows a cytotoxic
effect characterized by typical morphological alterations, detach-
ment of cells from the substrate and disruption of cell monolayer,
compared with untreated cells. The maximum non-toxic concen-
tration (MNTC) of each extract was  determined. All extracts were
toxic at a concentration of 5000 g/mL but no extract showed cyto-
toxicity at 50 g/mL. In addition, four extracts showed MNTC to
500 g/mL, as shown in Table 3. The concentrations of the extracts
978 A.B. Cecílio et al. / Journal of Ethnopharmacology 141 (2012) 975– 981
Table 2
TLC conditions to test the presence of different classes of natural products in the ethanolic extracts.
Class Eluent Spray
Tannins Toluene:acetic acid:formic acid (70:167:14) K3Fe(CN)6 1%:FeCl3 2% (1:1)
Flavonoids Ethylacetate:methanol:water (176:22:22) AlCl3 reagent (2%)
Anthraquinones Toluene:acetone:chloroform (40:25:35) KOH reagent (5%)
Terpenes Hexane:ethylacetate (1:1) Anisaldehyde-sulfuric acid reagent
Cardiotonic glycosides Ethylacetate:methanol:water (20:3:2) Kedde reagent
Alkaloids Ethylacetate:formic acid:acetic acid:water:ethylmethylcetone (86:16:23:47:78) Dragendorff reagent
Coumarins Toluene:chloroform:acetone (145:53:53) KOH reagent (5%)
Saponins Chloroform:acetic acid:methanol:water (112:60:22:15) Anisaldehyde-sulfuric acid reagent
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Viral infections are the cause of many human and animal
diseases that have a signiﬁcant economic impact. The limited
availability of antiviral drugs could be partially attributed to theig. 1. The rhesus monkey kidney cell line MA-104. (A) Untreated control cells. (B) 
lant  extract (magniﬁcation, 20×).
howing cytotoxic effect on MA-104 cells were excluded from the
ntiviral assay.
The extracts that were able to inhibit the viral CPE on MA-
04 cells and prevent viral replication at 10 and 20 TCID50, were
onsidered potentially active against rotavirus. Fig. 2A shows unin-
ected cells and Fig. 2B shows the typical CPE induced by the
irus in MA-104 cells. The morphological data observed in optical
icroscopy were compared with the molecular data by RT-PCR.
able 4 presents the results of RT-PCR, which were consistent
ith previous CPE data. Byrsonima verbascifolia, Eugenia dysen-
erica, Hymenaea courbaril and Myracrodruon urundeuva showed
PE inhibition of the virus at 10 and 20 TCID50 and Astronium
raxinifolium only at 10 TCID50 when they were tested at a concen-
ration of 500 g/mL. No extract showed inhibition of the CPE at
0 g/mL.
able 3
valuation of the cytotoxicity of crude extracts at 5000, 500 and 50 g/mL in MA-104
ells after 48 h of incubation.
Species 5000 g/mL 500 g/mL 50 g/mL
Anacardium humile + − −
Annona crassiﬂora + + −
Astronium fraxinifolium + − −
Byrsonima coccolobifolia + + −
Byrsonima verbascifolia + − −
Campomanesia pubescens + − −
Curatella americana + − −
Eugenia dysenterica + − −
Eugenia uniﬂora + + −
Hymenaea courbaril + − −
Luehea paniculata + − −
Myracrodruon urundeuva + − −
Psidium guajava + − −
Stryphnodendron adstringens + + −
, presence of cytotoxicity; −, absence of cytotoxicity.l toxic effect observed in cells after 48 h of incubation with toxic concentrations of
3.1. Phytochemical screening
The phytochemical screening revealed that tannins, ﬂavonoids,
terpenes and saponins were the major classes of natural products
found in the leaf extracts of the medicinal species studied (Table 5),
while anthraquinones, cardiotonic glycosides and alkaloids were
not detected.
4. DiscussionTable 4
Conventional RT-PCR analysis of material collected after incubation for 48 h of MA-
104  cells with rotavirus at 10 or 20 TCID50 and crude extracts at concentrations of
50  or 500 g/mL.
Species 500 g/mL 50 g/mL
10 TCID50 20 TCID50 10 TCID50 20 TCID50
Anacardium humile + + + +
Annona crassiﬂora ND ND + +
Astronium fraxinifolium − + + +
Byrsonima coccolobifolia ND ND + +
Byrsonima verbascifolia − − + +
Campomanesia pubescens + + + +
Curatella americana + + + +
Eugenia dysenterica − − + +
Eugenia uniﬂora ND ND + +
Hymenaea courbaril − − + +
Luehea paniculata + + + +
Myracrodruon urundeuva − − + +
Psidium guajava + + + +
Stryphnodendron adstringens ND ND + +
−, no ampliﬁcation; +, speciﬁc rotavirus ampliﬁcation; ND, not done (the concen-
trations of the extracts that showed cytotoxic effect on MA-104 cells were excluded
from testing).
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A11,  after 48 h of incubation (magniﬁcation, 20×).
ifﬁculty of ﬁnding targets for drugs that eliminate the virus with-
ut harming the host cells (Cock and Kalt, 2010). Natural products
rom higher plants and marine organisms represent an almost
nexhaustible resource of antiviral drug leads (Palombo, 2006;
agar et al., 2010; Yasuhara-Bell et al., 2010). Several natural com-
ounds including polysaccharides, ﬂavonoids, terpenes, alkaloids,
henolics and amino acids showing antiviral activity have been
solated from plants used in traditional medicine (Vlietinck and
anden Berghe, 1991; Longanga et al., 2000; Palombo, 2006). These
ompounds may  be involved in the defense of the plants against
nvading pathogens such as insects, bacteria, fungi, and viruses
Friedman, 2007).
In the present study, in vitro assays were established and
mployed to detect antiviral activity of extracts obtained from
lants traditionally used to treat intestinal disorders as well as other
iseases in accordance with an ethnopharmacological approach. As
ur main objective was to perform a rapid screening of the poten-
ial activity of these extracts against rotavirus, we decided to work
ith rhesus monkey kidney MA-104 cells and simian rotavirus
A11. MA-104 cells are the most used cells in experiments with
A11 due to their susceptibility to this virus, and their ability to
how typical cytopathic and cytotoxic effects easily identiﬁed by
ptical microscopy within 48 h. Simian rotavirus SA11 was  cho-
en because it is well characterized and is the most widely used
eference strains in laboratories throughout the world (Malherbe
nd Strickland-Cholmley, 1967; Estes et al., 1979; López and Arias,
992; Goncalves et al., 2005; Westerman et al., 2006). The leaf crude
xtracts were resuspended in DMSO to a concentration of 50 mg/mL
nd we checked the cytotoxicity of the extracts for MA-104 cells. In
able 5
hytochemical screening and yields of ethanolic crude extracts of leaves.
Species Extract yield (%) Natural products class
Tan Fla 
Anacardium humile 26.7 + + 
Annona crassiﬂora 40.9 + + 
Astronium fraxinifolium 29.0 + + 
Byrsonima coccolobifolia 22.1 + + 
Byrsonima verbascifolia 28.9 + + 
Campomanesia pubescens 23.6 + + 
Curatella americana 16.1 + + 
Eugenia dysenterica 21.0 + + 
Eugenia uniﬂora 26.2 + + 
Hymenaea courbaril 16.9 + + 
Luehea  paniculata 18.5 + + 
Myracroduon urundeuva 19.4 + + 
Psidium guajava 15.6 + + 
Stryphnodendron adstringens 31.6 + + 
an, tannins; Fla, ﬂavonoids; Ant, anthraquinones; Ter, terpenes; Car Gly, cardiotonic glyr. (B) Typical cytopathic effect observed in cells infected with the simian rotavirus
general, the extracts showed low cytotoxicity, which was  expected,
since the plant species chosen are already used by the population to
treat some diseases. The toxicity at a concentration of 5000 g/mL
observed in all extracts, may  be due to the 10% DMSO present in
these dilutions of the extract, since the control (10% DMSO, with-
out plant extract) was  also toxic to cells. However, most of the
extracts were not able to inhibit viral replication and the formation
of CPE in infected cells. These results suggest that the antidiar-
rhoeal effects can occur in different situations other than those
caused by rotavirus, such as by other pathogens or pathophysiolog-
ical diarrhoeal condition. However, the results do not discard the
role of these extracts for the treatment of diarrhoea. In addition,
the symptoms of viral infection can be alleviated by compounds
present in the selected plants, without necessarily requiring a direct
action against the virus. For example, Roner et al. (2010) have sug-
gested that saponins will ‘coat’ the epithelium of the host’s small
intestine and prevent attachment of rotavirus. On the other hand,
some saponins have also been shown to exhibit direct virucidal
mechanisms of action, including destruction of viral envelopes and
interaction with host cell membranes, leading to the loss of viral
binding sites (Arstila, 1974; Abe et al., 1981).
The species Byrsonima verbascifolia, Myracrodruon urundeuva,
Eugenia dysenterica and Hymenaea courbaril exhibited the strongest
in vitro activity against rotavirus. Their extracts prevented the
formation of CPE, and RT-PCR analysis detected no ampliﬁ-
cation of genetic material from rotavirus. The RT-PCR data
suggest that in the leaves of these plants there are bioac-
tive molecules capable of inhibiting viral replication. Tannins,
ﬂavonoids, saponins, coumarins and terpenes were the major
es
Ant Ter Car Gly Alk Cou Sap
− + − − + +
− + − − − +
− + − − + −
− + − − + +
− + − − + +
− − − − − +
− + − − − +
− + − − − +
− + − − + +
− + − − + −
− + − − − −
− + − − + +
− + − − + +
− + − − − +
cosides; Alk, alkaloids; Cou, coumarins; Sap, saponins; +, presence; −, absence.
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lasses of natural products found in the leaf extracts that showed
ntiviral activity. Most of these classes have been reported
n plants that have shown antidiarrhoeal activity (Lima et al.,
011).
In the present study, the compounds that may  be respon-
ible for the antiviral activity have not been identiﬁed. Unlike
hose observed for Byrsonima verbascifolia and Myracrodruon
rundeuva,  which showed all classes of metabolites previously
entioned, the extract of Eugenia dysenterica did not show
he presence of coumarins, while saponins were not found in
ymenaea courbaril. However, extracts of both plants still showed
nhibitory activity on the replication of rotavirus, according to
ata from the RT-PCR. Astronium fraxinifolium showed partial
ntiviral activity, because it was not able to inhibit viral replica-
ion when the amount of virus increased from 10 to 20 TCID50.
ccording to the phytochemical screening, the same classes
f metabolites mentioned for those species that showed the
trongest antiviral activity against rotavirus were also detected
n the extract of Astronium fraxinifolium with the exception of
aponins.
Lopez et al. (2001) also observed antiviral activity of Byrsonima
erbascifolia against herpes simplex virus. Phytochemical studies
arried out previously also described the presence of triterpenes in
he leaves of this species (Gottlieb et al., 1975).
Some phytochemical and biological studies with these four
ore active plants have been reported in literature. Essential oil
rom the leaves of Eugenia dysenterica were showed to inhibit the
rowth of Candida species and Cryptococcus neofarmans isolated
rom HIV infected patients (Costa et al., 2000). In agreement with
ur results, the presence of tannins in the leaves was  also reported
y Palhares (2003).  Many sesquiterpenes and diterpenes (Nogueira
t al., 2001) have been isolated from Hymenaea courbaril, and some
f them showed cytotoxicity for tumour cells (Abdel-Kader et al.,
002).
Pre-clinical and clinical studies with the bark of Myracrodruon
rundeuva showed anti-inﬂammatory, analgesic, wound healing
nd antiulcer activity (Goes et al., 2005). From its seeds were iso-
ated quercetin, aromadendrinol and biﬂavonoid (Goes et al., 2005).
lavonoids are dietary components and the most ubiquitous pheno-
ic compounds found in nature, showing a range of pharmacological
ctivities, including antiviral action (Bae et al., 2000; Cushnie and
amb, 2005; Friedman, 2007; Li et al., 2008). Previous studies have
emonstrated that some ﬂavonoids (diosmin and hesperidin) were
ble to inhibit rotavirus propagation, as well as protect the cell
ultures against virus invasion (Bae et al., 2000).
It is important to mention that the in vitro activity against simian
otavirus SA11 reported here are only the preliminary results. How-
ver, they encourage further studies to evaluate the leaf extracts
rom Byrsonima verbascifolia, Myracrodruon urundeuva,  Eugenia
ysenterica and Hymenaea courbaril using other antiviral assays
gainst rotavirus, such as tests with other cell lines, and in vivo
ssay with murine rotavirus strains in mice (Ward et al., 1990;
cNeal et al., 2004; Goncalves et al., 2005; Westerman et al., 2006).
hese will conﬁrm the results from the present work as well as to
nvestigate possible mechanisms of action. It will be interesting to
btain the active plant extracts by the bioassay-guided fraction-
tion and isolation of bioactive compounds. The crude extracts
an contain other compounds which were not detected by the
hytochemical screening that can be active to inhibit or kill the
irus. Ongoing experiments are being performed by our research
roup aiming to identify the possible anti-rotavirus fraction(s) or
ompound(s) bioactive(s), and the results will be reported in due
ourse.
The present study corroborates ethnopharmacological data as a
aluable source in the selection of plants with antiviral activity and
o some extent validates their traditional uses.rmacology 141 (2012) 975– 981
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